logo
ATO reveals $5.7 billion superannuation issue costing millions in retirement: 'Stamp out'

ATO reveals $5.7 billion superannuation issue costing millions in retirement: 'Stamp out'

Yahoo15-07-2025
Australians are losing $5.7 billion in retirement savings each year due to employers not paying their superannuation entitlements correctly, new analysis of Australian Taxation Office (ATO) data has revealed. The huge losses have sparked calls for 'payday super' reforms to be passed when parliament returns this month.
About 3.3 million Australians missed out on superannuation entitlements, averaging $1,730, in the 2022-2023 financial year, Super Members Council analysis of taxation data found. The amount of super going unpaid increased by $600 million from the previous year, with workers now losing $110 million each week.
More than one million people were underpaid super in New South Wales at an average of $1,760, more than 848,000 in Victoria at an average of $1,670, and more than 679,000 in Queensland, missing out on an average $1,720.
RELATED
Aussie cafe owner's 'pressure' of impending $124,000 superannuation change
NAB, ANZ slash interest rates as lenders move despite RBA cash rate hold: 'Not a coincidence'
ATO tax return warning for 2 million Aussies over dangerous act
Payday super reforms will mean employers are required to pay their employees' superannuation at the same time as their salary and wages. Under the current rules, it only has to be done quarterly.
The reform, first announced in May 2023, is due to come into effect from July next year. However, it has not yet been legislated by the government.
Super Members Council Deputy CEO Georgia Brumby said any delays to the law would mean less money in retirement for Australians, which means "less money to pay the bills after a lifetime of hard work".
'The sooner this legislation is introduced and passed, the more time and certainty it will give businesses and the super payment system to prepare — so all workers can get paid their super on time and in full,' she said.
'Payday super will not only stamp out unpaid super — it'll put nearly $8,000 more in the average Australian's pocket at retirement, thanks to more frequent payments and the power of compounding.'Leading accounting bodies have been calling on the government to delay the planned start date of the legislation.
CPA Australia, CA ANZ and the Tax Institute said they all support the plan but have argued the July 1, 2026 date is 'unreasonable' and 'should be deferred for, ideally, 24 months, but at least 12 months'.
They have argued the payment of super is more complex than wages and involves clearing houses, payment gateways and super funds.
Employers will be given a seven-calendar-day deadline from the payment of wages to pay superannuation. If this is missed, they will be liable for an updated super guarantee charge which would include the shortfall, daily interest and an extra enforcement charge.
In November, the ATO revealed its actions had led to $932 million in previously unpaid super reaching the retirement accounts of 797,000 employees in the past year.
The ATO noted that more than 92 per cent of super entitlements were paid without the need for ATO intervention. Employees can check their super account via myGov to see what super payments have been paid into their funds.
If you suspect your super hasn't been paid in full, on time and to the correct fund, the ATO recommends checking with your employer and your nominated super fund.
You can report unpaid super to the ATO.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

A 59-Year-Old Career Nurse Feels 'Defeated And Cooked' After Learning Her Coworker Has Saved Nearly $500,000 More For Retirement
A 59-Year-Old Career Nurse Feels 'Defeated And Cooked' After Learning Her Coworker Has Saved Nearly $500,000 More For Retirement

Yahoo

time25 minutes ago

  • Yahoo

A 59-Year-Old Career Nurse Feels 'Defeated And Cooked' After Learning Her Coworker Has Saved Nearly $500,000 More For Retirement

A longtime nurse approaching retirement recently posted on Reddit that he felt 'defeated and cooked' after discovering a coworker had $460,000 more saved in their 401(k). He shared his financial situation on the r/retirement subreddit, noting that he and his wife have about $240,000 saved for retirement, plus an anticipated $1,100 monthly pension, Social Security benefits between $1,800 and $2,300, and roughly $200,000 to $300,000 in other savings. 'I absolutely can't grind out eight more years working full-time,' he said. Dissapointment 'I was feeling OK about my plan,' he wrote, 'until talking with a coworker in the same salary range who has managed to save about $700,000 in his 401(k).' Don't Miss: Be part of the breakthrough that could replace plastic as we know it— $100k+ in investable assets? – no cost, no obligation. Many redditors urged the nurse to stop comparing himself to others. 'Comparison is the thief of joy,' one commenter said. Another added, 'You were fine until you found out someone else has more? You're 59, not 9. Way past time to stop playing that childish game.' Several pointed out that his pension is a valuable asset often overlooked. 'That pension is huge,' one person said. 'It may not sound like a lot, but you would need about $400,000 in savings to be able to withdraw $1,100 per month.' Others focused on his emotional exhaustion. The nurse explained he could not imagine working full-time for another eight years, prompting many to suggest transitioning into a less physically demanding role like remote case management or a teaching role. Trending: This AI-Powered Trading Platform Has 5,000+ Users, 27 Pending Patents, and a $43.97M Valuation — Most Americans Fall Short Of Retirement Goals While Fidelity recommends that Americans have eight times their salary saved by age 60, the reality for most people falls short. So while the nurse may not be hitting expert targets, he's still ahead of the typical American. Many commenters emphasized that retirement readiness comes down to spending, not just savings. 'Your expenses drive how long you have to work,' one said. 'What are your expected retirement expenses per month including health insurance? Know that and you can figure out how long you need to work.' Some shared their own modest setups. One retired couple said they live well off a $2,900 pension, $1,100 Social Security check, and $200,000 in cash. Their monthly expenses total just $2,200, largely due to living in a low-cost area and owning a small recurring tip: test-drive their retirement budget now. That means they should try living on what they'd expect to bring in each month during retirement. If they can live on it now, they can probably live on it then. The nurse eventually responded to the outpouring of support and practical advice. 'Thank you everyone for the advice and recommendations,' he wrote. Fellow Redditors encouraged him to speak to a fee-only financial advisor and to start tracking his monthly expenses to create a concrete plan. 'It's useless [to] feel bad about what you were not able to accomplish in the past,' one nurse wrote. 'Start learning today and figure out how you can make your dreams happen.' Read Next: Can you guess how many retire with a $5,000,000 nest egg? .Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? APPLE (AAPL): Free Stock Analysis Report TESLA (TSLA): Free Stock Analysis Report This article A 59-Year-Old Career Nurse Feels 'Defeated And Cooked' After Learning Her Coworker Has Saved Nearly $500,000 More For Retirement originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.

Biotech Is Booming, and This Undervalued REIT Stands to Gain
Biotech Is Booming, and This Undervalued REIT Stands to Gain

Yahoo

timean hour ago

  • Yahoo

Biotech Is Booming, and This Undervalued REIT Stands to Gain

While most commercial office landlords are still hunting for post‑pandemic tenants, there's a sector of the real estate industry that's breeding breakout growth: life sciences. Global biotech spending is projected to triple from roughly $1.7 trillion in 2025 to more than $5 trillion by 2034. All that R&D cash needs purpose‑built laboratory space. That's what makes Alexandria Real Estate Equities (NYSE: ARE) such a standout real estate investment trust (REIT). It owns the largest portfolio of labs and life-science properties in the United States and has a client base of approximately 750 high-quality tenants, including Eli Lilly, Moderna, and Bristol-Myers Squibb. With this strong tenant base, Alexandria is poised to generate returns that could replicate like stem cells. Tenants engineered for long-term occupancy With occupancy rates of 92% and the majority of their space leased to biotech, pharmaceutical, and agricultural technology (AgTech), Alexandria is in a league of its own in comparison to other REITs. Given the highly specialized nature of their business, laboratory tenants require customized spaces, so they sign longer leases and rarely move. Thanks to this, last quarter, ARE locked in rent increases of 18.5% on average when tenants renewed and 7.5% when new ones signed, a strong sign of pricing power even during a period of lower leasing demand. The company also has a weighted-average remaining lease term of 7.6 years, indicating strong tenant commitment and predictable long-term cash flow, boosting the company's overall income stability. With a lease portfolio this stable, you could call it genetically engineered for sizable returns. Rebuilding the balance sheet with surgical precision Instead of chasing growth for growth's sake, management has been smartly recycling capital. During 2024, it focused on selling noncore assets to free up cash, reduce debt exposure, and reinvest funds into higher-yielding developments, an approach that improves returns while lowering long-term risk. For 2025, it plans another $2 billion of dispositions and minority‑interest sales, roughly one third of which is already closed or under contract. Proceeds are being funneled into its high‑margin mega‑campus developments that have consistently proven profitable for ARE, further strengthening the company's financial position. Only 13 % of outstanding debt matures before 2028, and the average term is now over 12 years, which is longer than any other REIT in the S&P 500 (SNPINDEX: ^GSPC). Incubating tomorrow's rent roll Even with occupancy not at full capacity, Alexandria has roughly 4 million square feet of Class A lab projects under construction in Boston, San Diego, and the Bay Area. Much of that space is pre‑leased, and the rest should command premium rents once biotech funding rebounds. Combined with contractually built-in rent escalators that will boost revenue annually even without new leases, that pipeline points to rising cash flow in the near future. After paying dividends, the company still expects to retain roughly $475 million of operating cash this year, enough to self‑fund a good chunk of its expansion. Potential side effects to monitor Investors should keep in mind that, while the long-term outlook for the life sciences industry is favorable, demand can be cyclical. If the biotech funding window slams shut due to larger macroeconomic trends, leasing of ARE's new projects could slow. Rising interest rates are another wild card. Alexandria's current interest‑rate swaps shield it for now, but costs will climb when that protection rolls off. Additionally, biotech companies operate on long R&D cycles. If a wave of Alexandria's tenants hit clinical trial setbacks or fail to bring products to market, they may downsize or go out of business, reducing demand for space. Management already trimmed its 2025 adjusted funds from operations (AFFO) guidance after a small dip in occupancy and higher interest expense. As AFFO is a key metric used to assess a REIT's true operating performance and its ability to support dividends, any downward revision can signal slower growth or pressure on dividend safety if trends persist. The company also missed its Q1 2025 earnings per share (EPS) forecast, reporting a $0.07 loss per share versus the $0.76 expected. While EPS isn't as relevant as FFO for REITs, the miss still raised questions about timing of asset sales, operating expenses, and lease activity. Investors should watch closely to make sure management follows through on its efficiency and disposition goals in upcoming quarters. A prescription for income and upside Alexandria currently trades around $71 a share and yields a 7.27% dividend, far above the 4% average REIT payout. More importantly, last quarter's dividend used just 57% of FFO. That's considered a conservative payout ratio for a REIT, suggesting that the company isn't stretching itself to pay investors. ARE also appears to be extremely undervalued right now. It trades approximately 7x forward FFO, lower than many other high-quality REITs, especially those with stable tenants and strong growth prospects. Shares still trade more than 65% below their 2021 peak, meaning ARE offers both attractive yield today and potential upside tomorrow. For income seekers willing to stomach a bit of volatility, Alexandria Real Estate Equities looks like a REIT worth implanting into a diversified portfolio. Should you buy stock in Alexandria Real Estate Equities right now? Before you buy stock in Alexandria Real Estate Equities, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Alexandria Real Estate Equities wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $636,774!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,064,942!* Now, it's worth noting Stock Advisor's total average return is 1,040% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 21, 2025 The Motley Fool has positions in and recommends Alexandria Real Estate Equities and Bristol Myers Squibb. The Motley Fool recommends Moderna. The Motley Fool has a disclosure policy. Biotech Is Booming, and This Undervalued REIT Stands to Gain was originally published by The Motley Fool

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store